Table 2.

Mean continuous glucose monitoring, glucose management indicator, and percentage of time spent in glucose ranges greater than 250 mg/dL, 181 to 250 mg/dL, 70 to 180 mg/dL, less than 70 mg/dL, and less than 54 mg/dL across all time points

	Baseline	1 mo	3 mo	6 mo	9 mo	12 mo	P a
	n = 52	n = 55	n = 67	n = 70	n = 68	n = 67
Mean glucose, mg/dL	176 ± 39	147 ± 28	147 ± 29	162 ± 35	161 ± 33	168 ± 34	< .001
GMI, %	7.5 ± 0.9	6.8 ± 0.7	6.8 ± 0.7	7.2 ± 0.8	7.2 ± 0.8	7.3 ± 0.8	< .001
CGM glucose range, mg/dL, %
> 250	15.1 ± 17.1	6.7 ± 10.7	7.2 ± 9.8	11.5 ± 13.2	10.9 ± 12.3	13.0 ± 13.6	< .001
181-250	26.4 ± 10.9	16.3 ± 8.6	16.0 ± 9.7	21.1 ± 10.8	21.5 ± 10.7	23.6 ± 9.7	< .001
70-180	57.2 ± 22.5	74.6 ± 16.7	74.6 ± 17.7	65.5 ± 21.2	65.5 ± 20.1	61.3 ± 20.3	< .001
< 70 b	1.2 ± 2.1	2.4 ± 2.4	2.3 ± 2.2	1.9 ± 2.4	2.1 ± 2.1	2.1 ± 2.7	.47
< 54 c	0.2 ± 0.5	0.4 ± 0.5	0.3 ± 0.3	0.3 ± 0.6	0.3 ± 0.4	0.3 ± 0.6	.83

All data reported as mean ± SD.

Abbreviations: CGM, continuous glucose monitoring; GMI, glucose management indicator; IQRs, interquartile ranges.

^a P value represents slope from 1 month post diagnosis to 12 months post diagnosis for each category.

^b Median (IQRs) for less than 70 mg/dL were 0.3 (0.0-1.6), 1.8 (0.7-3.2), 1.9 (0.8-3.0), 1.2 (0.4-2.5), 1.4 (0.7-3.2), and 1.4 (0.6-2.5) from baseline through 12 months post diagnosis, respectively.

^c Median (IQRs) for less than 54 mg/dL were 0.0 (0.0-0.2), 0.2 (0.0-0.5), 0.2 (0.0-0.3), 0.1 (0.0-0.2), 0.2 (0.0-0.4), and 0.1 (0.1-0.3) from baseline through 12 months post diagnosis, respectively.